Results 101 to 110 of about 20,003 (228)
Background: Streptococcus pneumoniae remains a leading cause of bacterial meningitis worldwide. Although pneumococcal conjugate vaccines (PCVs) have markedly reduced vaccine serotypes (VTs) invasive pneumococcal disease, the emergence of non-vaccine ...
Ching-Min Tang +8 more
doaj +1 more source
Summary: Background: India accounts for a disproportionate burden of global childhood illnesses. To inform policies and measure progress towards achieving child health targets, we estimated the annual national and state-specific childhood mortality and ...
Brian Wahl, PhD +16 more
doaj +1 more source
Background In China, the measles vaccine is offered for free whereas the pneumococcal vaccine is a for-fee vaccine. This difference has the potential to influence how caregivers evaluate whether a vaccine is important or necessary for their child, but it
Abram L. Wagner +7 more
doaj +1 more source
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis [PDF]
Treatment of bacterial meningitis caused by Streptococcus pneumoniae is increasingly difficult, because of emerging resistance to antibiotics. Recombinant Cpl-1, a phage lysin specific for S.
Grandgirard, Denis +7 more
core +1 more source
Progranulin Plays a Protective Role in Pneumococcal Meningitis by Inhibiting Pyroptosis
Objective Pneumococcal meningitis is a serious infectious disease with a high mortality rate and a global presence, and survivors have different degrees of neurological sequelae as a consequence of the host response to the infection.
Jingyao Wang +9 more
doaj +1 more source
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis. [PDF]
BACKGROUND Pneumococcal meningitis is associated with high risk of neurological sequelae such as cognitive impairment and hearing loss. These sequelae are due to parenchymal brain and inner ear damage primarily induced by the excessive inflammatory ...
Grandgirard, Denis +4 more
core +1 more source
Effects of clinically used antioxidants in experimental pneumococcal meningitis [PDF]
Reactive oxygen intermediates mediate brain injury in bacterial meningitis. Several antioxidant drugs are clinically available, including N-acetylcysteine (NAC), deferoxamine (DFO), and trylizad-mesylate (TLM).
Pfister, Luz-Andrea +4 more
core +1 more source
Background Pneumococcal infections are major causes of morbidity and mortality worldwide. We use routine hospital admissions data and time-series modelling analysis to estimate the impact of the seven and thirteen valent pneumococcal conjugate vaccines ...
Tinevimbo Shiri +2 more
doaj +1 more source
Genetic Variation in NFKBIE Is Associated With Increased Risk of Pneumococcal Meningitis in Children
Background: Streptococcus pneumoniae and Neisseria meningitidis are frequent pathogens in life-threatening infections. Genetic variation in the immune system may predispose to these infections.
Lene F. Lundbo +8 more
doaj +1 more source

